U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Advanced Marginal Zone Lymphoma

MedGen UID:
1768546
•Concept ID:
C5419607
•
Neoplastic Process

Definition

Marginal zone lymphoma that has spread extensively to other anatomic sites or is no longer responding to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAdvanced Marginal Zone Lymphoma

Professional guidelines

PubMed

Marginal zone lymphoma: 2023 update on diagnosis and management.
Cheah CY, Seymour JF
Am J Hematol 2023 Oct;98(10):1645-1657. Epub 2023 Aug 21 doi: 10.1002/ajh.27058. PMID: 37605344
Management of marginal zone lymphomas.
Merli M, Arcaini L
Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):676-687. doi: 10.1182/hematology.2022000362. PMID: 36485086Free PMC Article
Contemporary management of nodal and primary splenic marginal zone lymphoma.
Leslie LA, Feldman TA, McNeill A, Timberg M, Iida H, Goy AH
Expert Rev Hematol 2019 Dec;12(12):1011-1022. Epub 2019 Nov 12 doi: 10.1080/17474086.2020.1681962. PMID: 31619091

Recent clinical studies

Etiology

PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S
Semin Nucl Med 2023 May;53(3):320-351. Epub 2022 Dec 14 doi: 10.1053/j.semnuclmed.2022.11.001. PMID: 36522191
Recent advances in cutaneous lymphoma-implications for current and future classifications.
Goodlad JR, Cerroni L, Swerdlow SH
Virchows Arch 2023 Jan;482(1):281-298. Epub 2022 Oct 24 doi: 10.1007/s00428-022-03421-5. PMID: 36278991Free PMC Article
Current Treatments in Marginal Zone Lymphoma.
Alderuccio JP, Kahl BS
Oncology (Williston Park) 2022 Apr 6;36(4):206-215. doi: 10.46883/2022.25920956. PMID: 35436062
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS
Lancet Oncol 2022 Jan;23(1):91-103. Epub 2021 Dec 8 doi: 10.1016/S1470-2045(21)00591-X. PMID: 34895487
Marginal zone lymphoma: Associated autoimmunity and auto-immune disorders.
Teixeira Mendes LS, Wotherspoon A
Best Pract Res Clin Haematol 2017 Mar-Jun;30(1-2):65-76. Epub 2016 Nov 5 doi: 10.1016/j.beha.2016.07.006. PMID: 28288719

Diagnosis

PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S
Semin Nucl Med 2023 May;53(3):320-351. Epub 2022 Dec 14 doi: 10.1053/j.semnuclmed.2022.11.001. PMID: 36522191
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C, Cook JR, Yoshino T, Quintanilla-Martinez L, Jaffe ES
Virchows Arch 2023 Jan;482(1):149-162. Epub 2022 Nov 17 doi: 10.1007/s00428-022-03432-2. PMID: 36394631Free PMC Article
CXCR4-targeted theranostics in oncology.
Buck AK, Serfling SE, Lindner T, Hänscheid H, Schirbel A, Hahner S, Fassnacht M, Einsele H, Werner RA
Eur J Nucl Med Mol Imaging 2022 Oct;49(12):4133-4144. Epub 2022 Jun 8 doi: 10.1007/s00259-022-05849-y. PMID: 35674738Free PMC Article
Current Treatments in Marginal Zone Lymphoma.
Alderuccio JP, Kahl BS
Oncology (Williston Park) 2022 Apr 6;36(4):206-215. doi: 10.46883/2022.25920956. PMID: 35436062
Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM, Castillo JJ
Hematol Oncol Clin North Am 2019 Aug;33(4):639-656. Epub 2019 Apr 30 doi: 10.1016/j.hoc.2019.03.004. PMID: 31229160

Therapy

Conjunctival Lymphoma.
McGrath LA, Ryan DA, Warrier SK, Coupland SE, Glasson WJ
Eye (Lond) 2023 Apr;37(5):837-848. Epub 2022 Jul 26 doi: 10.1038/s41433-022-02176-2. PMID: 35882984Free PMC Article
Current Treatments in Marginal Zone Lymphoma.
Alderuccio JP, Kahl BS
Oncology (Williston Park) 2022 Apr 6;36(4):206-215. doi: 10.46883/2022.25920956. PMID: 35436062
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS
Lancet Oncol 2022 Jan;23(1):91-103. Epub 2021 Dec 8 doi: 10.1016/S1470-2045(21)00591-X. PMID: 34895487
Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM, Castillo JJ
Hematol Oncol Clin North Am 2019 Aug;33(4):639-656. Epub 2019 Apr 30 doi: 10.1016/j.hoc.2019.03.004. PMID: 31229160
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Xu-Monette ZY, Zhou J, Young KH
Blood 2018 Jan 4;131(1):68-83. Epub 2017 Nov 8 doi: 10.1182/blood-2017-07-740993. PMID: 29118007Free PMC Article

Prognosis

PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S
Semin Nucl Med 2023 May;53(3):320-351. Epub 2022 Dec 14 doi: 10.1053/j.semnuclmed.2022.11.001. PMID: 36522191
Conjunctival Lymphoma.
McGrath LA, Ryan DA, Warrier SK, Coupland SE, Glasson WJ
Eye (Lond) 2023 Apr;37(5):837-848. Epub 2022 Jul 26 doi: 10.1038/s41433-022-02176-2. PMID: 35882984Free PMC Article
Current Treatments in Marginal Zone Lymphoma.
Alderuccio JP, Kahl BS
Oncology (Williston Park) 2022 Apr 6;36(4):206-215. doi: 10.46883/2022.25920956. PMID: 35436062
Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM, Castillo JJ
Hematol Oncol Clin North Am 2019 Aug;33(4):639-656. Epub 2019 Apr 30 doi: 10.1016/j.hoc.2019.03.004. PMID: 31229160
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Xu-Monette ZY, Zhou J, Young KH
Blood 2018 Jan 4;131(1):68-83. Epub 2017 Nov 8 doi: 10.1182/blood-2017-07-740993. PMID: 29118007Free PMC Article

Clinical prediction guides

PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, Paccagnella A, Farina A, Broccoli A, Casadei B, Zinzani PL, Fanti S
Semin Nucl Med 2023 May;53(3):320-351. Epub 2022 Dec 14 doi: 10.1053/j.semnuclmed.2022.11.001. PMID: 36522191
Conjunctival Lymphoma.
McGrath LA, Ryan DA, Warrier SK, Coupland SE, Glasson WJ
Eye (Lond) 2023 Apr;37(5):837-848. Epub 2022 Jul 26 doi: 10.1038/s41433-022-02176-2. PMID: 35882984Free PMC Article
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS
Lancet Oncol 2022 Jan;23(1):91-103. Epub 2021 Dec 8 doi: 10.1016/S1470-2045(21)00591-X. PMID: 34895487
Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM, Castillo JJ
Hematol Oncol Clin North Am 2019 Aug;33(4):639-656. Epub 2019 Apr 30 doi: 10.1016/j.hoc.2019.03.004. PMID: 31229160
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Xu-Monette ZY, Zhou J, Young KH
Blood 2018 Jan 4;131(1):68-83. Epub 2017 Nov 8 doi: 10.1182/blood-2017-07-740993. PMID: 29118007Free PMC Article

Recent systematic reviews

Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis.
Keikha M, Sahebkar A, Yamaoka Y, Karbalaei M
J Health Popul Nutr 2022 Jan 3;41(1):2. doi: 10.1186/s41043-021-00280-9. PMID: 34980267Free PMC Article
Borrelia burgdorferi in primary cutaneous lymphomas: a systematic review and meta-analysis.
Travaglino A, Varricchio S, Pace M, Russo D, Picardi M, Baldo A, Staibano S, Mascolo M
J Dtsch Dermatol Ges 2020 Dec;18(12):1379-1384. Epub 2020 Oct 8 doi: 10.1111/ddg.14289. PMID: 33029842
Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review.
van den Brand M, van Krieken JH
Haematologica 2013 Jul;98(7):1003-13. doi: 10.3324/haematol.2012.083386. PMID: 23813646Free PMC Article
Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
Sokol L, Naghashpour M, Glass LF
Cancer Control 2012 Jul;19(3):236-44. doi: 10.1177/107327481201900308. PMID: 22710899
Primary low-grade and high-grade gastric MALT-lymphoma presentation.
Zullo A, Hassan C, Andriani A, Cristofari F, Cardinale V, Spinelli GP, Tomao S, Morini S
J Clin Gastroenterol 2010 May-Jun;44(5):340-4. doi: 10.1097/MCG.0b013e3181b4b1ab. PMID: 19745757

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...